Eloxx Pharmaceuticals Inc
OTC:ELOX

Watchlist Manager
Eloxx Pharmaceuticals Inc Logo
Eloxx Pharmaceuticals Inc
OTC:ELOX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 314 USD

Operating Margin
Eloxx Pharmaceuticals Inc

0%
Current
0%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-19.3m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Eloxx Pharmaceuticals Inc
Glance View

Market Cap
306.8 USD
Industry
Pharmaceuticals

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The company is headquartered in Watertown, Massachusetts and currently employs 28 full-time employees. The company went IPO on 2012-11-23. The firm is focused on developing ribonucleic acid (RNA)-modulating drug candidates, each designed to be a eukaryotic ribosomal selective glycoside (ERSG), formulated to treat rare and ultra-rare premature stop codon diseases. The firm's lead product candidate, ELX-02, is a small molecule designed to restore production of full-length functional proteins. ELX-02 is in clinical development for systemic administration for cystic fibrosis. The firm is also conducting investigational new drug (IND)-enabling preclinical studies of ERSG compounds for autosomal dominant polycystic kidney disease (ADPKD) and in rare inherited retinal disorders (IRDs) by intravitreal administration with an initial focus on Usher Syndrome. Its preclinical candidate pool consists of a library of ERSG drug candidates identified based on read-through potential and cytoplasmic ribosomal selectivity.

ELOX Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-19.3m
/
Revenue
0
What is the Operating Margin of Eloxx Pharmaceuticals Inc?

Based on Eloxx Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top